11/09/2016 - 12:22pm
Business Insider is reporting that as news that Donald Trump will be the 45th president sent stocks into an early Thursday tumble in Europe, by around 9:50 a.m. in London (4:50 a.m. EST), pharmaceutical stocks were rising, with Hikma Pharmaceuticals’s stock up 6% on the FTSE 100. Roche and Novartis saw stock increases over 4% and GSK saw a 1.8% bump. Jefferies pointed to hope that efforts to enact new pricing rules on drugs led the swell, telling Business Insider, “Sentiment towards the Healthcare sector ought to swing initially away from draconian fears over drug pricing.” (Business Insider)
 
 
11/08/2016 - 2:02pm

Novartis' Heart Partner app makes it easy to track daily vitals, store key health information and coordinate care and activities with others.

11/07/2016 - 3:30pm

The Propeller platform works to help patients better understand asthma and COPD and help improve the symptoms and outcomes of chronic respiratory diseases. 

11/02/2016 - 7:15am

The flu vaccination service is under the responsibility of a nurse or a pharmacist, depending on the province in which the store is located, the Jean Coutu Group noted.

11/01/2016 - 5:41am

Veru Healthcare will manage the pharma and consumer health divisions and The Female Health Company will manage the global Public Health sector FC2 business.

10/31/2016 - 11:09am

Under the agreement, AstraZeneca will continue to manufacture and supply the drug and its authorized generic to Aralex Ireland for at least 10 years, and it will continue to distribute the product until it is transferred, which could be up to nine months after closing. 

10/31/2016 - 8:17am

According to UNICEF, 19.4 million children missed out on basic vaccines needed to stay healthy last year. Almost one third of deaths among children under five are preventable by vaccines.

10/28/2016 - 11:07am

Restasis Multidose has a unidirectional valve and air filter technology that the company says eliminates the need for a preservative, and the bottle uses less plastic than a package of single-use vials.

10/28/2016 - 10:54am

In a move that would expand its oncology pipeline, Astellas Pharma announced Friday its agreement to acquire Ganymed Pharmaceuticals for €422 million, or about $461 million.